Increased Detectability of Alpha Brain Glutamate/Glutamine in Neonatal Hypoxic-Ischemic Encephalopathy

References

1. ↵
   Rivkin MJ. Hypoxic-ischemic brain injury in the term newborn: neuropathology, clinical aspects and neuroimaging. Clin Perinatol 1997;24:607-625

   PubMedWeb of Science
2. ↵
   Cotman CW, Iversen LL. Excitatory amino acids in the brain: focus on NMDA receptors. Trends Neurosci 1987;10:263-265

   CrossRefWeb of Science
3. ↵
   Cataltepe O, Towfighi J, Vannucci RC. Cerebrospinal fluid concentrations of glutamate and GABA during perinatal cerebral hypoxia-ischemia and seizures. Brain Res 1996;709:326-330

   CrossRefPubMed
4. ↵
   Ottersen OP, Laake JH, Reichelt W, Haug FM, Torp R. Ischemic disruption of glutamate homeostasis in brain: quantitative immunocytochemical analyses. J Chem Neuroanat 1996;12:1-14

   CrossRefPubMedWeb of Science
5. ↵
   Erecinska M, Silver IA. Metabolism and role of glutamate in mammalian brain. Prog Neurobiol 1990;35:245-296

   CrossRefPubMedWeb of Science
6. Philis JW, O'Regan MH. Mechanisms of glutamate and aspartate release in the ischemic rat cerebral cortex. Brain Res 1996;730:150-164

   CrossRefPubMedWeb of Science
7. Kanthan R, Shuaib A, Griebel R, Miyashita H. Intracerebral human microdialysis: in vivo study of acute focal ischemic model of the human brain. Stroke 1995;26:870-873

   Abstract/FREE Full Text
8. Hajek M, Do KQ, Boesiger P, Wieser HG. Increased excitatory amino acid levels in brain cysts of epileptic patients. Epilepsy Res 1997;28:245-254

   CrossRefPubMed
9. Podell M, Hadjiconstantinou M. Cerebrospinal fluid gamma-aminobutyric acid and glutamate values in dogs with epilepsy. Am J Vet Res 1997;58:451-456

   PubMedWeb of Science
10. ↵
    Rothman SM, Olney JW. Glutamate and the pathophysiology of hypoxic/ischemic brain damage. Ann Neurol 1986;19:105-111

    CrossRefPubMedWeb of Science
11. Rothman SM, Olney JW. Excitotoxicity and the NMDA receptor. Trends Neurosci 1987;10:299-302

    CrossRefWeb of Science
12. Choi D. Methods for antagonizing glutamate neurotoxicity. Cerebrovasc Brain Metab Rev 1990;2:105-147

    PubMedWeb of Science
13. ↵
    du Plessis AJ, Johnston MV. Hypoxic-ischemic brain injury in the newborn, cellular mechanisms and potential strategies for neuroprotection. Clin Perinatol 1997;24:627-654

    PubMedWeb of Science
14. ↵
    Mason GF, Pan JW, Ponder SL, Twieg DB, Pohost GM, Hetherington HP. Detection of brain glutamate and glutamine in spectroscopic images at 4.1 T. Magn Reson Med 1994;32:142-145

    PubMed
15. ↵
    McConnell JR, Antonson DL, Ong CS, et al. Proton spectroscopy of brain glutamine in acute liver failure. Hepatology 1995;22:69-74

    CrossRefPubMedWeb of Science
16. ↵
    Ross B, Michaelis T. Clinical application of magnetic resonance spectroscopy. Magn Reson Q 1994;10:191-247

    PubMedWeb of Science
17. Bachelard H, Badar-Goffer R. NMR spectroscopy in neurochemistry. J Neurochem 1993;61:412-429

    PubMedWeb of Science
18. ↵
    Rothman DL, Hanstock CC, Petroff OAC, Novotny EJ, Prichard JW, Shulman RG. Localized ¹H MRS spectra of glutamate in human brain. Magn Reson Med 1992;25:94-106

    CrossRefPubMed
19. ↵
    Connelly A, Cross JH, Gadian DG, Hunter JV, Kirkham FJ, Leonard JV. Magnetic resonance spectroscopy shows increased brain glutamine in ornithine carbamoyl transferase deficiency. Pediatr Res 1993;33:77-81

    PubMedWeb of Science
20. ↵
    Kauppinen RA, Williams SR. Nondestructive detection of glutamate by ¹H nuclear magnetic resonance spectroscopy in cortical brain slices from the guinea pig: evidence for changes in detectability during severe anoxic insults. J Neurochem 1991;57:1136-1144

    CrossRefPubMed
21. Kauppinen RA, Pirttila TRM, Auriola SOK, Williams SR. Compartmentation of cerebral glutamate in situ as detected by ¹H and ¹³C n.m.r. Biochem J 1994;298:121-127

    Abstract/FREE Full Text
22. ↵
    Kreis R, Arcinue E, Ernst T, Shonk TK, Flores R, Ross BD. Hypoxic encephalopathy after near-drowning studied by quantitative ¹H-magnetic resonance spectroscopy: metabolic changes and their prognostic value. J Clin Invest 1996;97:1142-1154

    CrossRefPubMedWeb of Science
23. ↵
    Huppi PS, Barnes PD. Magnetic resonance techniques in the evaluation of newborn brain. Clin Perinatol 1997;24:693-723

    PubMed
24. Penrice J, Cady EB, Lorek A, et al. Proton magnetic resonance spectroscopy of brain in normal preterm and term infants, and early changes following perinatal hypoxia-ischemia. Pediatr Res 1996;40:6-14

    CrossRefPubMedWeb of Science
25. Groenendaal F, Veenhoven RH, Van Der Grond J, Jansen GH, Witkamp TD, De Vries LS. Cerebral lactate and N-acetyl-aspartate/choline ratios in asphyxiated full-term neonates demonstrated in vivo using proton magnetic resonance spectroscopy. Pediatr Res 1994;35:148-151

    CrossRefPubMedWeb of Science
26. Peden CJ, Rutherford MA, Sargentoni J, Cox IJ, Bryant DJ, Dubowitz LMS. Proton spectroscopy of the neonatal brain following hypoxic-ischemic injury. Dev Med Child Neurol 1993;35:502-510

    PubMedWeb of Science
27. Hanrahan JD, Sargentoni J, Azzopardi D, et al. Cerebral metabolism within 18 hours of birth asphyxia: proton magnetic resonance spectroscopy study. Pediatr Res 1996;39:584-590

    PubMedWeb of Science
28. Peden CJ, Cowan FM, Bryant DJ, et al. Proton MR spectroscopy of brain in infants. J Comput Assist Tomogr 1990;14:886-894

    CrossRefPubMedWeb of Science
29. Cady EB, Amess P, Penrice J, Wylezinska M, Sams V, Wyatt JS. Early cerebral-metabolite quantification in perinatal hypoxic-ischemic encephalopathy by proton and phosphorus magnetic resonance spectroscopy. Magn Reson Imaging 1997;15:605-611

    CrossRefPubMedWeb of Science
30. ↵
    Bottomley PA. Spatial localization in NMR spectroscopy in vivo.. Ann N Y Acad Sci 1987;508:333-348

    CrossRefPubMedWeb of Science
31. ↵
    Frahm J, Bruhn H, Gyngell ML, Merboldt KD, Hanicke W, Sauter R. Localized high-resolution proton NMR spectroscopy using stimulated echoes: initial applications to human brain in vivo. Magn Reson Med 1989;9:79-93

    CrossRefPubMedWeb of Science
32. Haase A, Frahm J, Matthaei D, et al. MR imaging using stimulated echoes (STEAM). Radiology 1986;160:787-790

    PubMed
33. ↵
    Sarnat HBO, Sarnat MS. Neonatal encephalopathy following fetal distress: a clinical and electroencephalographic study. Arch Neurol 1976;33:696-705

    CrossRefPubMedWeb of Science
34. ↵
    Barkovich AJ. MR and CT evaluation of profound neonatal and infantile asphyxia. AJNR Am J Neuroradiol 1992;13:959-972

    Abstract/FREE Full Text
35. Dambska M, Dydyk L, Szreter T, Wozniewicz J, Myers RE. Topography of lesions in newborn and infant brains following cardiac arrest and resuscitation: damage to brain and hemispheres. Bio Neonate 1976;29:194-206
36. Leech RW, Alvordm EC Jr. Anoxic-ischemic encephalopathy in human neonatal period. Arch Neurol 1977;34:109-113

    CrossRefPubMedWeb of Science
37. Schneider H, Ballowitz L, Schachinger H, Hanefeld F, Droszus JU. Anoxic encephalopathy with predominant involvement of basal ganglia, brain stem and spinal cord in perinatal period: report on seven newborns. Acta Neuropathol 1975;32:287-298

    CrossRefPubMed
38. ↵
    Ernst T, Hennig J. Improved water suppression of localized in vivo ¹H spectroscopy. J Magn Reson B 1995;106:181-186

    CrossRefPubMed
39. de Graaf AA, Bovee WMM. Improved quantification of in vivo ¹H NMR spectra by optimization of signal acquisition and processing and by incorporation of prior knowledge into spectral fitting. Magn Reson Med 1990;15:305-319

    CrossRefPubMedWeb of Science
40. ↵
    Govindaraju V, Basus VJ, Matson GB, Maudsley AA. Measurement of chemical shifts and coupling constants for glutamate and glutamine. Magn Reson Med 1998;39:1011-1013

    CrossRefPubMed
41. ↵
    Erecinska M, Nelson D, Wilson DF, Silver IA. Neurotransmitter amino acids in the CNS, I: regional changes in amino acid levels in rat brain during ischemia and reperfusion. Brain Res 1984;304:9-22

    CrossRefPubMedWeb of Science
42. Hagberg H, Lehmann A, Sandberg M, Nystrom B, Jacobson I, Hamberger A. Ischemia-induced shift of inhibitory and excitatory amino acids from intra- to extra-cellular compartments. J Cereb Blood Flow Metab 1985;5:413-419

    CrossRefPubMedWeb of Science
43. Spisni A. 1D Spectrum analysis. In: De Certaines JD, Bovee WWMJ, Podo F, eds. Magnetic Resonance Spectroscopy in Biology and Medicine. Oxford: Pergramon; 1992:31-58
44. Cady EB. Clinical Magnetic Resonance Spectroscopy.. New York: Plenum; 1990:47-81
45. ↵
    Mathur-De Ver R, Delporte C. Relaxation times of relevant nuclei in biological systems. In: De Certaines JD, Bovee WWMJ, Podo F, eds. Magnetic Resonance Spectroscopy in Biology and Medicine. Oxford: Pergramon; 1992:77-96
46. ↵
    Moonen CT, von Kienlin M, van Zijl PC, et al. Comparison of single-shot localization methods (STEAM and PRESS) for in vivo proton NMR spectroscopy. NMR Biomed 1989;2:201-208

    CrossRefPubMed
47. ↵
    Benveniste H, Warner D. The role of glutamatergic neurotransmission in ischemic brain damage. In: Ginsberg MD, Bogousslavslky J, eds. Cerebrovascular Disease, Pathophysiology, Diagnosis and Management. Malden, MA: Blackwell Science; 1998:393-402
48. Meldrum BS. Antagonism of excitatory amino acids. In: Ginsberg MD, Bogousslavslky J, eds. Cerebrovascular Disease, Pathophysiology, Diagnosis and Management. Malden, MA: Blackwell Science; 1998:682-692
49. ↵
    Stasheff SF, Anderson WW, Clerk S, Wilson WA. NMDA antagonists differentiate epileptogenesis from seizure expression in an in vitro model. Science 1989;245:648-651

    Abstract/FREE Full Text
50. Hu RQ, Davies JA. Glutamate receptor antagonists reduce spontaneous epileptiform activity in cortical wedge prepared from DBA/2 mice. Exp Brain Res 1997;115:311-318

    CrossRefPubMed
51. ↵
    Mukherji SK. Clinical Applications of MR Spectroscopy.. New York: Wiley; 1998:1-32
52. Ernst T, Hennig J. Coupling effects in volume selective ¹H spectroscopy of major brain metabolites. Magn Reson Med 1991;21:82-96

    CrossRefPubMed